Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Dianthus Therapeutics (DNTH) Leases (2022 - 2025)

Dianthus Therapeutics has reported Leases over the past 4 years, most recently at $1.3 million for Q3 2025.

  • Quarterly results put Leases at $1.3 million for Q3 2025, up 271.02% from a year ago — trailing twelve months through Sep 2025 was $1.3 million (up 271.02% YoY), and the annual figure for FY2024 was $1.6 million, up 152.52%.
  • Leases for Q3 2025 was $1.3 million at Dianthus Therapeutics, down from $1.4 million in the prior quarter.
  • Over the last five years, Leases for DNTH hit a ceiling of $25.4 million in Q1 2022 and a floor of $352000.0 in Q3 2024.
  • Median Leases over the past 4 years was $1.3 million (2025), compared with a mean of $6.4 million.
  • Biggest five-year swings in Leases: crashed 97.08% in 2023 and later surged 271.02% in 2025.
  • Dianthus Therapeutics' Leases stood at $814000.0 in 2022, then fell by 24.45% to $615000.0 in 2023, then soared by 152.52% to $1.6 million in 2024, then fell by 15.9% to $1.3 million in 2025.
  • The last three reported values for Leases were $1.3 million (Q3 2025), $1.4 million (Q2 2025), and $1.4 million (Q1 2025) per Business Quant data.